Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A. Khan, MD, Andrew J. Meltzer, MD, Katherine A. Gallagher, MD, James F. McKinsey, MD, Darren B. Schneider, MD Journal of Vascular Surgery Volume 55, Issue 2, Pages 371-380 (February 2012) DOI: 10.1016/j.jvs.2011.08.044 Copyright © 2012 Society for Vascular Surgery Terms and Conditions
Fig 1 Primary patency is shown in the control group (blue line) and the statin group (green line). Journal of Vascular Surgery 2012 55, 371-380DOI: (10.1016/j.jvs.2011.08.044) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
Fig 2 Secondary patency is shown in the control group (blue line) and the statin group (green line). Journal of Vascular Surgery 2012 55, 371-380DOI: (10.1016/j.jvs.2011.08.044) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
Fig 3 Limb salvage is shown in the control group (blue line) and the statin group (green line). Journal of Vascular Surgery 2012 55, 371-380DOI: (10.1016/j.jvs.2011.08.044) Copyright © 2012 Society for Vascular Surgery Terms and Conditions
Fig 4 All-cause mortality is shown in the control group (blue line) and the statin group (green line). Journal of Vascular Surgery 2012 55, 371-380DOI: (10.1016/j.jvs.2011.08.044) Copyright © 2012 Society for Vascular Surgery Terms and Conditions